返回ChemicalBook首页>CAS数据库列表>6106-07-6

6106-07-6

中文名称 左旋甲状腺素钠五水合物
英文名称 Sodium levothyroxine pentahydrate
CAS 6106-07-6
分子式 C15H20I4NNaO9
MDL 编号 MFCD00149110
分子量 888.93
MOL 文件 6106-07-6.mol
6106-07-6 结构式 6106-07-6 结构式

基本信息

中文别名
3',3,5',5-四碘甲腺原氨酸钠盐五水合物
O-(4-羟基-3,5-二碘苯基)-3,5-二碘-L-酪氨酸单钠盐五水合物
左旋甲状腺素钠五水合物
英文别名
3,3',5,5'-TETRAIODO-L-THYRONINE SODIUM SALT PENTAHYDRATE
3-[4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL]-L-ALANINE PENTAHYDRATE
3-[4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL]-L-ALANINE SODIUM SALT PENTAHYDRATE
L-THYROXINE SODIUM PENTAHYDRATE
L-THYROXINE SODIUM SALT PENTAHYDRATE
(S)-2-AMINO-3-[4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL]PROPIONIC ACID SODIUM SALT PENTAHYDRATE
SODIUM LEVOTHYROXINE PENTAHYDRATE
SODIUM (S)-2-AMINO-3-[4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3,5-DIIODOPHENYL]PROPIONATE PENTAHYDRATE
3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)-alaninmonosodiumsa
lt,pentahydrate,
l-tyrosine,o-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-,sodiumsalt,pentahydra
o-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-l-tyrosinesodiumsaltpentahydrate
L-thyroxine sodium pentahydrate*gamma-irradiated
sodium L-4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzylalaninate pentahydrate
L-THYROXINE, SODIUM SALT PENTAHYDRATE, 9 9%
L-THYROXINE SODIUM PENTAHYDRATE*GAMMA-IR RADIATED CE
L-Thyroxinesodiumsaltpentahydratecrystalline
3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-l-alanine sodium salt
O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine monosodium salt pentahydrate
SODIUM L-THYROXINE PENTAHYDRATE
所属类别
医药中间体:原料药中间体

物理化学性质

熔点207-210 (dec.)(lit.)
比旋光度[α]D20 +15~+19°
密度2.381
储存条件2-8°C
溶解度cell culture medium: 0.1 mg/mL
形态powder
形态粉末
颜色白色到黄色到橙色
BRN5721845

安全数据

危险性符号(GHS)
GHS08
警示词危险
危险性描述H372
危险品标志Xn
危险类别码40
安全说明S22-S24/25
WGK Germany3
RTECS号YP2833760

知名试剂公司产品信息

左旋甲状腺素钠五水合物价格(试剂级)
报价日期产品编号产品名称CAS号包装价格
2024/01/25HY-18341A左旋甲状腺素钠五水合物
L-Thyroxine sodium salt pentahydrate
6106-07-6500mg650元
2024/01/25HY-18341A左旋甲状腺素钠五水合物
L-Thyroxine sodium salt pentahydrate
6106-07-610mM * 1mLin DMSO715元
2024/01/25HY-18341A左旋甲状腺素钠五水合物
L-Thyroxine sodium salt pentahydrate
6106-07-61g850元

常见问题列表

生物活性
L-Thyroxine sodium salt pentahydrate (Levothyroxine; T4) 是一种合成的甲状腺激素,用于甲状腺功能减退症的研究。DIO 酶将 L-Thyroxine (T4) 转化成具有生物活性的三碘甲状腺氨酸 (T3)。
靶点

Thyroid Hormone Receptor

体内研究

Deiodinases (DIOs), which catalyse the conversion of thyroxine (pro-hormone) to the active thyroid hormone, are associated with thyroid stimulating hormone (TSH) levels. DIO1 and DIO2 catalyze activation of thyroid hormone secretion in contrast to DIO3 playing role inactivation of the secretion. Activities of DIO1 and DIO2 play pivotal role in the negative feedback regulation of pituitary TSH secretion. L-Thyroxine (T4) and Triiodothyronine (T3) hormones are known to modulate the expression of ionic channels, pumps and regulatory contractile proteins. Moreover, thyroid hormones have been shown to influence calcium homeostasis and flux responsible for excitation and contractility, with L-Thyroxine and Triiodothyronine modulating its pharmacological control and secretion. In rats fed 12 weeks with the iodine-free diet, a significant decrease in the levels of both Triiodothyronine and L-Thyroxine is observed when compared to the control group fed with standard diet (p<0.001). In the group treated with low doses of L-Thyroxine, an increase in L-Thyroxine levels is observed (p=0.02) while Triiodothyronine levels remain virtually similar to the control group (p=0.19). Rats treated with high doses of L-Thyroxine display a significant increase in both Triiodothyronine and L-Thyroxine circulating concentrations compared to the non-treated hypothyroid group (p<0.001 and p=0.004, respectively) and a significant increase in L-Thyroxine levels when compared to the control values (p=0.03).

"6106-07-6" 相关产品信息
7601-54-9 1914-99-4 51-48-9 25416-65-3 15307-79-6 1310-73-2 144-55-8 127-09-3 60-18-4 6893-02-3 99-11-6 70642-86-3 87-89-8 532-32-1 300-30-1 7647-14-5 515-25-3 103129-82-4